Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Apr
25
2024
Germany Posts Information on Dossier Submitter’s Ongoing Role in Proposed REACH Restriction for PFAS Bergeson & Campbell, P.C.
Apr
25
2024
CMS Advises Preparatory Steps for Anticipated PrEP Coverage Transition to Medicare Part B McDermott Will & Emery
Apr
25
2024
Florida DOR Proposes Update to Agricultural Real Property Appraisal Guidelines Jones Walker LLP
Apr
25
2024
Federal Circuit Affirms Obviousness of Rifaximin Polymorph Patents and Denial of Motion to Modify Judgment After Post-Trial Patented Indication Carve Out Mintz
Apr
25
2024
FTC Moves to Strike Most Noncompetes: Considerations for Cannabis Companies Bradley Arant Boult Cummings LLP
Apr
25
2024
New Favorable OIG Advisory Opinion Allows Patient Assistant Programs Funded by Drug Manufacturers Foley & Lardner LLP
Apr
25
2024
Utility of Consortia Advocacy — A Conversation with Heather J. Blankinship [Podcast] Bergeson & Campbell, P.C.
Apr
25
2024
Florida's Division of Alcoholic Beverages and Tobacco Posts 2023 Quota Lottery Winners List Jones Walker LLP
Apr
24
2024
New York’s New Alcohol Beverage Control Law Amendments Affect State Liquor License Applicants Greenberg Traurig, LLP
Apr
24
2024
FDA Continues to Take Stance That it Will Not Issue CBD Rules Foley & Lardner LLP
Apr
24
2024
Trending in Telehealth: March 26 – April 1, 2024 McDermott Will & Emery
Apr
24
2024
Court Dismisses Lawsuit Targeting “All Natural” Claim Keller and Heckman LLP
Apr
24
2024
This Week in 340B: April 16 – April 22, 2024 McDermott Will & Emery
Apr
23
2024
EUON Welcomes New Study Proposals Bergeson & Campbell, P.C.
Apr
23
2024
CMS Publishes Final Rules Implementing Part C and Part D Program Changes Mintz
Apr
23
2024
Litigation Minute: The Lifecycle of Beauty Packaging K&L Gates
Apr
23
2024
AMS Publishes RFI on Electronic and Digital Link Disclosures under the National Bioengineered Food Disclosure Standard Bergeson & Campbell, P.C.
Apr
23
2024
A Greener World Asks FSIS to Seek Input on “Free Range” and “Pasture-Raised” Claims Keller and Heckman LLP
Apr
22
2024
FDA Chief Says CBD Is Not NBD, Urges Congressional Action Bradley Arant Boult Cummings LLP
Apr
22
2024
NY AG Launches Greenwashing Lawsuit Against Beef Producer Mintz
Apr
21
2024
Off-Duty Conduct Protections for Employees’ 4/20 Celebrations: A Look at the High Points of a Few States’ Marijuana Laws Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Apr
19
2024
HRSA Aims for Swift Dispute Resolution with new 340B ADR Final Rule Polsinelli PC
Apr
19
2024
Money Trees (and Office Greens): Why Real Estate Developers are Transforming Vacant Office Spaces into Trendy Urban Farms ArentFox Schiff LLP
Apr
19
2024
HHS-OIG Highlights Anti-Fraud Safeguards for Patient Assistance Programs Backed Mainly By Drug Manufacturers Barnes & Thornburg LLP
Apr
18
2024
March 2024 Bounty Hunter Plaintiff Claims Keller and Heckman LLP
Apr
18
2024
DOJ Just Said the Quiet Part Out Loud in Massachusetts Cannabis Case Bradley Arant Boult Cummings LLP
Apr
18
2024
Supreme Court Declines to Review FDA Labeling Preemption for State Claims Keller and Heckman LLP
Apr
18
2024
FDA Preemption of State Law for False Labeling Survives Appeal to Supreme Court Polsinelli PC
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins